117091-64-2COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OP(=O)(O)OLIQODXNTTZAGID-OCBXBXKTSA-NEtoposide phosphate is a furonaphthodioxole.
117091-64-2CHEMBL1200645CHEBI:135867FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
White crystalline powder
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Danger
H228 (50%): Flammable solid [Danger Flammable solids]
P203, P210, P240, P241, P260, P264, P270, P273, P280, P301+P317, P318, P319, P330, P370+P378, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
ETOPOSIDE PHOSPHATE
Topoisomerase Inhibitors [MoA]; Topoisomerase Inhibitor [EPC]
용도As a bioequivalent prodrug of the DNA topoisomerase II inhibitor Etoposide (E933750), Etoposide phosphate can be used in the treatment of a wide variety of hematological malignancies and solid tumors.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…